Comparative immunogenicities of full-length Plasmodium falciparum merozoite surface protein 3 and a 24-kilodalton N-terminal fragment

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1221-1228

  Imam, Maryam ^a   Devi, Yengkhom Sangeeta ^a   Verma, Akhilesh K ^b   Chauhan, Virander Singh ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; MEROZOITE SURFACE PROTEIN 3; MEROZOITE SURFACE PROTEIN 3 N TERMINAL FRAGMENT; MICROORGANISM PROTEIN; MONTANIDE ISA 720; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR INHIBITION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MEROZOITE; MONOCYTE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RABBIT;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ESCHERICHIA COLI; FREEZE DRYING; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; MALARIA VACCINES; MALE; MANNITOL; MICE; MICE, INBRED BALB C; MONOCYTES; OLEIC ACIDS; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTEIN STABILITY; PROTOZOAN PROTEINS; RABBITS; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 79961110898     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00064-11     Document Type: Article

References (25)

1. Bouharoun-Tayoun, H., and P. Druilhe. 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60:1473-1481.
2. Bouharoun-Tayoun, H., C. Oeuvray, F. Lunel, and P. Druilhe. 1995. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182:409-418.
3. Burgess, B. R., P. Schuck, and D. N. Garboczi. 2005. Dissection of merozoite surface protein 3, a representative of a family of Plasmodium falciparum surface proteins, reveals an oligomeric and highly elongated molecule. J. Biol. Chem. 280:37236-37245. (Pubitemid 41587808)
4. Chauhan, V. S., S. S. Yazdani, and D. Gaur. 13 September 2010. Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum. Hum. Vaccin. [Epub ahead of print.]
5. Coler, R. N., D. Carter, M. Friede, and S. G. Reed. 2009. Adjuvants for malaria vaccines. Parasite Immunol. 31:520-528.
6. Corradin, G., and A. V. Kajava. 2010. Malaria vaccine: why is it taking so long? Expert Rev. Vaccines 9:111-114.
7. Corradin, G., A. V. Kajava, and A. Verdini. 2010. Long synthetic peptides for the production of vaccines and drugs: a technological platform coming of age. Sci. Transl. Med. 2:50-53.
8. Demanga, C. G., et al. 2010. Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans. Infect. Immun. 78:486-494.
9. Galamo, C. D., A. Jafarshad, C. Blanc, and P. Druilhe. 2009. Anti-MSP1 block 2 antibodies are effective at parasite killing in an allele-specific manner by monocyte-mediated antibody-dependent cellular inhibition. J. Infect. Dis. 199:1151-1154.
10. Girard, M. P., Z. H. Reed, M. Friede, and M. P. Kieny. 2007. A review of human vaccine research and development: malaria. Vaccine 25:1567-1580. (Pubitemid 46108198)
11. Gondeau, C., et al. 2009. The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer. Mol. Biochem. Parasitol. 165:153-161.
12. Hisaeda, H., et al. 2002. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. J. Infect. Dis. 185:657-664. (Pubitemid 34171471)
13. Holder, A. A., et al. 1994. Malaria parasites and erythrocyte invasion. Biochem. Soc. Trans. 22:291-295. (Pubitemid 24166170)
14. McColl, D. J., et al. 1994. Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 68:53-67. (Pubitemid 24358617)
15. Oeuvray, C., et al. 1994. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84:1594-1602. (Pubitemid 24273030)
16. Osier, F. H., et al. 2007. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 29:387-394. (Pubitemid 47083924)
17. Perignon, J. L., and P. Druilhe. 1994. Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem. Inst. Oswaldo Cruz 89(Suppl. 2):51-53.
18. Polley, S. D., et al. 2007. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J. Infect. Dis. 195:279-287. (Pubitemid 46080060)
19. Rasmussen, J. M., I. Brandslund, R. G. Leslie, and S. E. Svehag. 1983. Quantitative studies of Fc receptors on human monocytes: characterization by binding of homologous and heterologous monomeric IgG and soluble immune complexes of different composition. Immunology 49:537-544. (Pubitemid 13057552)
20. Sachdeva, S., G. Ahmad, P. Malhotra, P. Mukherjee, and V. S. Chauhan. 2004. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kilodalton fragments expressed in Escherichia coli. Infect. Immun. 72:5775-5782. (Pubitemid 39303688)
21. Singh, S., et al. 2004. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design. J. Infect. Dis. 190:1010-1018. (Pubitemid 39120982)
22. Singh, S., et al. 2009. A conserved gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum. PLoS One 4:e5410.
23. Soe, S., S. Singh, D. Camus, T. Horii, and P. Druilhe. 2002. Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing. Infect. Immun. 70:7182-7184. (Pubitemid 35390401)
24. Soe, S., M. Theisen, C. Roussilhon, K. S. Aye, and P. Druilhe. 2004. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect. Immun. 72:247-252. (Pubitemid 38018182)
25. Tsai, C. W., et al. 2009. Characterization of a protective Escherichia coliexpressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure. Mol. Biochem. Parasitol. 164:45-56.